EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance

Phuriwat Khiewkamrop, Chamraj Kaewraemruaen iD, Chonnavee Manipuntee, Chalathan Saengruengrit, Numpon Insin, Asada Leelahavanichkul, Warerat Kaewduangduen, Opor Sonpoung, Kasirapat Ariya-Anandech, Nattiya Hirankarn, Patcharee Ritprajak iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Phuriwat Khiewkamrop und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 1…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science research and Innovation Fund, Chulalongkorn University, NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, and the National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cells (DCs) are the most potent antigen-presenting cells that have multifaceted functions in the control of immune activation and tolerance. Hyperresponsiveness and altered tolerogenicity of DCs contribute to the development and pathogenesis of system lupus erythematosus (SLE); therefore, DC-targeted therapies aimed at inducing specific immune tolerance have become of great importance for the treatment of SLE. This study developed a new nanoparticle (NP) containing a biodegradable PDMAEMA-PLGA copolymer for target-oriented delivery to DCs in situ. PDMAEMA-PLGA NPs provided sustained drug release and exhibited immunosuppressive activity in FLT3L and GM-CSF-derived bone marrow in conventional DCs (BM-cDCs). PDMAEMA-PLGA NPs improved dexamethasone capability to convert wild-type and Fcgr2b-/- BM-cDCs from an immunogenic to tolerogenic state, and BM-cDCs treated with dexamethasone-incorporated PDMAEMA-PLGA NPs (Dex-NPs) efficiently mediated regulatory T cell (Treg) expansion in vitro. Dex-NP therapy potentially alleviated lupus disease in Fcgr2b-/- mice by mediating Foxp3+ Treg expansion in an antigen-specific manner. Our findings substantiate the superior efficacy of DC-targeted therapy using the PDMAEMA-PLGA NP delivery system and provide further support for clinical development as a potential therapy for SLE. Furthermore, PDMAEMA-PLGA NP may be a versatile platform for DC-targeted therapy to induce antigen-specific immune tolerance to unwanted immune responses that occur in autoimmune disease, allergy, and transplant rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicNanoparticlesMiceAnimalsAntigensImmune ToleranceImmunosuppressive AgentsDexamethasoneDendritic CellsReceptors, IgGMethacrylatesNylons

Stichwörter der Autor:innen

PDMAEMA-PLGA nanoparticlesdexamethasoneimmune tolerancelupus diseasetolerogenic dendritic cells

Substanzen

AntigensImmunosuppressive AgentsDexamethasoneReceptors, IgGpoly(2-(dimethylamino)ethyl methacrylate)MethacrylatesNylonsFcgr2b protein, mouse

Autor:innen und Institutionen

  • Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Immunology and Immune-Mediated Diseases, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Graduate Program in Medical Microbiology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Science and Bioinnovation, Faculty of Liberal Arts and Science, Kasetsart University, Kamphaeng Saen Campus, Nakhon Pathom 73104, Thailand.
  • Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • Bureau of Quality and Safety of Food, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.

ORCID-Profile: Chamraj Kaewraemruaen, Patcharee Ritprajak

Förderung

  • Thailand Science research and Innovation Fund, Chulalongkorn University
  • NSRF via the Program Management Unit for Human Resources & Institutional Development
  • Research and Innovation, and the National Research Council of Thailand
  • Second Century Fund (C2F), Chulalongkorn University
  • Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University
  • the NSRF via the Program Management Unit for Human Resources and Institutional Development
  • Program Management Unit for Human Resources and Institutional Development, Research and Innovation
  • Rachadapisek Sompote Matching Fund

Zitieren

APA

Khiewkamrop, P., Kaewraemruaen, C., Manipuntee, C., Saengruengrit, C., Insin, N., Leelahavanichkul, A., Kaewduangduen, W., Sonpoung, O., Ariya-Anandech, K., Hirankarn, N., & Ritprajak, P. (2023). Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098313

Vancouver

Khiewkamrop P, Kaewraemruaen C, Manipuntee C, Saengruengrit C, Insin N, Leelahavanichkul A, et al. Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098313

BibTeX
@article{Khiewkamrop2023,
  author = {Khiewkamrop, Phuriwat and Kaewraemruaen, Chamraj and Manipuntee, Chonnavee and Saengruengrit, Chalathan and Insin, Numpon and Leelahavanichkul, Asada and Kaewduangduen, Warerat and Sonpoung, Opor and Ariya-Anandech, Kasirapat and Hirankarn, Nattiya and Ritprajak, Patcharee},
  title = {Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098313}
}
Kostenlos starten →